Mankind Pharma Ltd. Announces 35th AGM and Annual Report 2025-26

Mankind Pharma Ltd. has announced its 35th Annual General Meeting (AGM) scheduled for August 4, 2026, to be held via Video Conferencing. The company has also released its Annual Report for the financial year 2025-26. Key agenda items include the adoption of standalone and consolidated financial statements, the reappointment of Mr. Rajeev Juneja as Director, and the re-appointment of Mr. Satish Kumar Sharma as Whole Time Director. The e-voting facility will be available from August 1 to August 3, 2026, and during the AGM. The cut-off date for determining voting eligibility is July 29, 2026.